Shares of INVO Fertility, Inc. (IVF), a healthcare fertility company, are up over 300% at $3.95 in premarket trading Tuesday, on no specific news.
Last month, the company signed a definitive purchase agreement to acquire Family Beginnings, P.C., a fertility clinic serving patients across Indiana and the broader Midwest. Family Beginnings generated revenue of approximately $1.2 million and net income of approximately $0.2 million for the trailing 12-month period ended September 30, 2025. The transaction is expected to close no later than February 27, 2026.
INVO's revenue from all clinics was $7.7 million for the full year of 2024, and $6.1 million for the first nine months of 2025. The company is targeting profitable, U.S.-based fertility businesses and aims to reach cash flow breakeven in 2026.
A 1-for-8 reverse stock split was implemented in November 2025, which marked the third reverse stock split for the year.
IVF closed Friday's trading at $0.81, up 0.11%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.